Preventing the transmission of HIV-1 and preserving pathogen-specific immunity in those already infected with HIV-1 (by initiating ART at higher CD4+ counts) will likely reduce the incidence of tuberculosis. This evidence concerns the gene CD4 and tuberculosis.